Our BWA panel discusses overreach at the Patented Medicine Prices Review Board, has a rejuvenating conversation about unreasonable delays in class action lawsuits, talks mitigation obligations for leasehold damages, and offers their views on constitutional overreach in the Competition Act (originally recorded on February 26, 2025).